Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Preclinical Species and Human Disposition of PF-04971729, a Selective Inhibitor of the Sodium-Dependent Glucose Cotransporter 2 and Clinical Candidate for the Treatment of Type 2 Diabetes Mellitus

Amit S. Kalgutkar, Meera Tugnait, Tong Zhu, Emi Kimoto, Zhuang Miao, Vincent Mascitti, Xin Yang, Beijing Tan, Robert L. Walsky, Jonathan Chupka, Bo Feng and Ralph P. Robinson
Drug Metabolism and Disposition September 2011, 39 (9) 1609-1619; DOI: https://doi.org/10.1124/dmd.111.040675
Amit S. Kalgutkar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meera Tugnait
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tong Zhu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emi Kimoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhuang Miao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Mascitti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xin Yang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beijing Tan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert L. Walsky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Chupka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Feng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralph P. Robinson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 39 no. 9 1609-1619
DOI 
https://doi.org/10.1124/dmd.111.040675
PubMed 
21690265

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received May 15, 2011
  • Accepted June 20, 2011
  • Published online August 19, 2011.

Article Versions

  • Earlier version (June 20, 2011 - 12:04).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Amit S. Kalgutkar,
  2. Meera Tugnait,
  3. Tong Zhu,
  4. Emi Kimoto,
  5. Zhuang Miao,
  6. Vincent Mascitti,
  7. Xin Yang,
  8. Beijing Tan,
  9. Robert L. Walsky,
  10. Jonathan Chupka,
  11. Bo Feng and
  12. Ralph P. Robinson
  1. Pharmacokinetics, Dynamics and Metabolism Department (A.S.K., M.T., T.Z., E.K., Z.M., X.Y., B.T., R.L.W., J.C., B.F.) and Worldwide Medicinal Chemistry (V.M., R.P.R.), Pfizer Global Research and Development, Groton, Connecticut
  1. Address correspondence to:
    Dr. Amit S. Kalgutkar, Pharmacokinetics, Dynamics, and Metabolism Department, Pfizer Global Research and Development, Groton, CT 06340. E-mail: amit.kalgutkar{at}pfizer.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to February 2023

AbstractFullPdf
Aug 2017103523
Sep 2017113620
Oct 201784921
Nov 201763720
Dec 201775317
Jan 201876119
Feb 201894316
Mar 2018233923
Apr 2018174316
May 201835019
Jun 2018103912
Jul 20186238
Aug 201893718
Sep 20183144
Oct 201855025
Nov 201864711
Dec 2018491616
Jan 20192922
Feb 20193066
Mar 201950169
Apr 20193877
May 20196038
Jun 201931410
Jul 201921116
Aug 201940143
Oct 20194947
Nov 20193632
Dec 20195955
Jan 20205553
Feb 20201753
Mar 20202313
May 20201545
Jun 20202045
Jul 20201411
Aug 20201113
Sep 20203723
Oct 20202286
Nov 20202534
Dec 20203634
Jan 20212767
Feb 20212786
Mar 20213963
Apr 20213765
May 20215285
Jun 20216485
Jul 20214296
Aug 2021351111
Sep 20211631
Oct 20213683
Nov 20212078
Dec 20214543
Jan 20222966
Feb 20221832
Mar 20225430
Apr 202244124
May 20225155
Jun 20223123
Jul 20222935
Aug 20223634
Sep 20222534
Oct 20223051
Nov 20225688
Dec 20221663
Jan 20232666
Feb 2023311

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 39 (9)
Drug Metabolism and Disposition
Vol. 39, Issue 9
1 Sep 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Preclinical Species and Human Disposition of PF-04971729, a Selective Inhibitor of the Sodium-Dependent Glucose Cotransporter 2 and Clinical Candidate for the Treatment of Type 2 Diabetes Mellitus
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Preclinical Species and Human Disposition of PF-04971729, a Selective Inhibitor of the Sodium-Dependent Glucose Cotransporter 2 and Clinical Candidate for the Treatment of Type 2 Diabetes Mellitus

Amit S. Kalgutkar, Meera Tugnait, Tong Zhu, Emi Kimoto, Zhuang Miao, Vincent Mascitti, Xin Yang, Beijing Tan, Robert L. Walsky, Jonathan Chupka, Bo Feng and Ralph P. Robinson
Drug Metabolism and Disposition September 1, 2011, 39 (9) 1609-1619; DOI: https://doi.org/10.1124/dmd.111.040675

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Preclinical Species and Human Disposition of PF-04971729, a Selective Inhibitor of the Sodium-Dependent Glucose Cotransporter 2 and Clinical Candidate for the Treatment of Type 2 Diabetes Mellitus

Amit S. Kalgutkar, Meera Tugnait, Tong Zhu, Emi Kimoto, Zhuang Miao, Vincent Mascitti, Xin Yang, Beijing Tan, Robert L. Walsky, Jonathan Chupka, Bo Feng and Ralph P. Robinson
Drug Metabolism and Disposition September 1, 2011, 39 (9) 1609-1619; DOI: https://doi.org/10.1124/dmd.111.040675
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Series-Compartment Models of Hepatic Elimination
  • Warfarin PBPK Model with TMDD Mechanism
  • Identification of payload-containing catabolites of ADCs
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics